Terms: = Germ cell tumor AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Clinical Outcome
10 results:
1. outcomes of Gamma Knife Surgery retreatment for growing vestibular schwannoma and review of the literature.
Hafez RFA; Morgan MS; Fahmy OM; Hassan HT
Clin Neurol Neurosurg; 2020 Nov; 198():106171. PubMed ID: 32927331
[TBL] [Abstract] [Full Text] [Related]
2. Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma.
Domingo-Musibay E; Heun JM; Nevala WK; Callstrom M; Atwell T; Galanis E; Erickson LA; Markovic SN
Oncologist; 2017 Sep; 22(9):1026-e93. PubMed ID: 28679643
[TBL] [Abstract] [Full Text] [Related]
3. Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697).
Butterfield LH; Zhao F; Lee S; Tarhini AA; Margolin KA; White RL; Atkins MB; Cohen GI; Whiteside TL; Kirkwood JM; Lawson DH
Clin Cancer Res; 2017 Sep; 23(17):5034-5043. PubMed ID: 28536308
[No Abstract] [Full Text] [Related]
4. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
Roszik J; Haydu LE; Hess KR; Oba J; Joon AY; Siroy AE; Karpinets TV; Stingo FC; Baladandayuthapani V; Tetzlaff MT; Wargo JA; Chen K; Forget MA; Haymaker CL; Chen JQ; Meric-Bernstam F; Eterovic AK; Shaw KR; Mills GB; Gershenwald JE; Radvanyi LG; Hwu P; Futreal PA; Gibbons DL; Lazar AJ; Bernatchez C; Davies MA; Woodman SE
BMC Med; 2016 Oct; 14(1):168. PubMed ID: 27776519
[TBL] [Abstract] [Full Text] [Related]
5. Adjunct endovascular interventions in carotid body tumors.
Economopoulos KP; Tzani A; Reifsnyder T
J Vasc Surg; 2015 Apr; 61(4):1081-91.e2. PubMed ID: 25814372
[TBL] [Abstract] [Full Text] [Related]
6. Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injection.
Ginsberg BA; Gallardo HF; Rasalan TS; Adamow M; Mu Z; Tandon S; Bewkes BB; Roman RA; Chapman PB; Schwartz GK; Carvajal RD; Panageas KS; Terzulli SL; Houghton AN; Yuan JD; Wolchok JD
Clin Cancer Res; 2010 Aug; 16(15):4057-65. PubMed ID: 20647477
[TBL] [Abstract] [Full Text] [Related]
7. clinical significance of serum NM23-H1 protein in neuroblastoma.
Okabe-Kado J; Kasukabe T; Honma Y; Hanada R; Nakagawara A; Kaneko Y
Cancer Sci; 2005 Oct; 96(10):653-60. PubMed ID: 16232196
[TBL] [Abstract] [Full Text] [Related]
8. Production and molecular characterization of clinical phase i anti-melanoma mouse IgG3 monoclonal antibody R24.
Kemminer SE; Conradt HS; Nimtz M; Sagi D; Peter-Katalinić J; Diekmann O; Drmić I; Müthing J
Biotechnol Prog; 2001; 17(5):809-21. PubMed ID: 11587568
[TBL] [Abstract] [Full Text] [Related]
9. Adrenal incidentalomas: surgical treatment in 28 patients and update of the literature.
Porcaro AB; Novella G; Ficarra V; Curti P; Antoniolli SZ; Suangwoua HS; Malossini G
Int Urol Nephrol; 2001; 32(3):295-302. PubMed ID: 11583337
[TBL] [Abstract] [Full Text] [Related]
10. Sinonasal melanoma. A clinicopathologic study of 25 cases and literature meta-analysis.
Brandwein MS; Rothstein A; Lawson W; Bodian C; Urken ML
Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):290-6. PubMed ID: 9076235
[TBL] [Abstract] [Full Text] [Related]
